If a patient meets standard rule-out (LSM <15 kPa and platelets >150×10⁹/L) but has high-risk clinical cues (e.g., diabetes with rising LSM, sarcopenic obesity, intermittent alcohol use), do you still defer CSPH-directed interventions, or do you trigger earlier reassessment/adjunct testing despite rule-out?